Redmile Group, LLC

Q4 2024 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    62

  • Value ($000)

    $1,434,861

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001425738
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$196.65M
14 %

4,549,881

KRYS
KRYS

KRYSTAL BIOTECH INC

COM
501147102
$117.99M
8 %

753,175

NRIX
NRIX

NURIX THERAPEUTICS INC

COM
67080M103
$78.99M
6 %

4,192,627

ZYME
ZYME

ZYMEWORKS INC

COM
98985Y108
$70.86M
5 %

4,840,463

FOLD
FOLD

AMICUS THERAPEUTICS INC

COM
03152W109
$66.46M
5 %

7,054,890

REPL
REPL

REPLIMUNE GROUP INC

COM
76029N106
$59.41M
4 %

4,905,527

IMNM
IMNM

IMMUNOME INC

COM
45257U108
$51.27M
4 %

4,828,026

STOK
STOK

STOKE THERAPEUTICS INC

COM
86150R107
$50.67M
4 %

4,593,629

---

LIVANOVA PLC

SHS
G5509L101
$48.33M
3 %

1,043,539

KYMR
KYMR

KYMERA THERAPEUTICS INC

COM
501575104
$44.27M
3 %

1,100,432

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 62